German biotech firm CureVac has enrolled the first participant for a Phase 2b/3 clinical trial of its COVID-19 vaccine candidate, it said on Monday.
U.S. health authorities, shipping services and hospitals stood ready on Friday to immediately launch a mass-inoculation campaign of unparalleled dimension, as federal...
Two adolescent siblings in the United States who signed up for a coronavirus vaccine trial said they did it because they wanted to make their own...
U.S. health authorities, shipping services and hospitals stood ready on Friday to immediately launch a mass-inoculation campaign of unparalleled dimension, as federal...
Health authorities, shipping services and hospitals, expecting imminent federal regulatory approval of the first COVID-19 vaccine in the United States, put final...
Boris Czajka knows how dangerous the coronavirus is. His wife Steffie suffered from an infection for months, and at the peak of her illness she would...
Australia cancelled the production of a locally made vaccine against COVID-19 after trials showed it could interfere with HIV diagnosis, with the government instead...
Britain's medicines regulator has advised people with a history of significant allergies not to get the Pfizer-BioNTech COVID-19 vaccine after two people reported...
Japan announced a fresh $708 billion economic stimulus package on Tuesday to speed up the recovery from the country's deep coronavirus-driven slump, while targeting...
Britain will start rolling out the COVID-19 vaccine developed by Pfizer and BioNTech on Tuesday, the first Western country to start vaccinating its general population...